1. Black, W.C., Gareen, I.F., Soneji, S.S., Sicks, J.D., Keeler, E.B., Aberle, D.R., Naeim, A., Church, T.R., Silvestri, G.A., Gorelick, J., Gatsonis, C.: Cost-effectiveness of CT screening in the National Lung Screening Trial. N. Engl. J. Med. 371(19), 1793–1802 (2014)
2. Fielderman, A., Silvester, G., Gatsonis, C.A., Hoenig, J., Flynn, S.: Prognostic significance of flow cytometric DNA analysis and proliferative index in stage I non-small cell lung cancer. Am. Rev. Respir. Dis. 146, 707–710 (1992)
3. Gareen, I.F., Duan, F., Greco, E.M., Snyder, B.S., Boiselle, P.M., Park, E.R., Fryback, D., Gatsonis, C.: Impact of lung cancer screening results on participant health-related quality of life and state anxiety in the National Lung Screening Trial. Cancer 120(21), 3401–3409 (2014)
4. Gatsonis, C.A.: Random effects models for diagnostic test accuracy. Acad. Radiol. 2, S14–S21 (1995)
5. Gatsonis, C., Carlos, R., Gareen, I., Gorelick, J., Kessler, L., Lau, J., Rutter, C., Schmid, C., Tosteson, A.N.A., Trikalinos, T.: Standards in the Design, Conduct and Evaluation of Diagnostic Testing for Use in Patient Centered Outcomes Research. Patient Centered Outcomes Research Institute (2012). http://www.pcori.org/assets/Standards-inthe-Design-Conduct-and-Evaluation-of-Diagnostic-Testing-for-Use-in-Patient-Centered-Outcomes-Research.pdf